GlassScriptPhysician profile
Mark Alan Schrumpf
NPI 1467648139
$267,876.34
in general payments reported to CMS, 2019-2025
9 companies · $136K in 2025
The $136K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,026 · 2020: $747 · 2021: $148 · 2022: $8,143 · 2023: $26K · 2024: $94K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $187K · Consulting Fee: $56K · Travel and Lodging: $10K · Food and Beverage: $2,072 · Gift: $74.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $187,211.54 |
| Consulting Fee | $56,025.00 |
| Travel and Lodging | $10,428.92 |
| Food and Beverage | $2,072.48 |
| Gift | $74.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $265,061.89 | 2019-2025 | Inset System |
| Wright Medical Technology, INC. | $1,189.36 | 2019 | |
| Exactech, INC. | $828.13 | 2019 | |
| Stryker Corporation | $483.32 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex, Aequalis Perform Reversed |
| Smith+Nephew, INC. | $139.73 | 2025 | Aetos Shoulder System |
| Catalyst Orthoscience | $101.77 | 2019 | |
| Evolution Surgical, INC | $31.49 | 2024 | |
| Merck Sharp & Dohme LLC | $24.01 | 2022 | |
| Depuy Synthes Sales INC. | $16.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schrumpf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.